Abbott Laboratories Completes $23 Billion Acquisition of Exact Sciences
ABBOTT PARK, Ill. — Abbott Laboratories (NYSE: ABT) has officially completed its $23 billion acquisition of Madison-based Exact Sciences, the maker of the Cologuard cancer screening test. The transaction, which…